MedTrace Logo

Effect of B-GOS on the Wellbeing and Ageing in Healthy 52-65 Years Old Individuals

NCT02716350 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2019-02-06

No results posted yet for this study

Summary

To investigate the potential of B-GOS to beneficially influence the wellbeing and ageing in healthy adults (52-65 years old). The study will consist of a 4 month randomised double blind parallel treatment period with either B-GOS of Placebo, and 1 month follow up period without treatments.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

B-GOS

comparison versus placebo

DIETARY_SUPPLEMENT

Maltodextrin

placebo

Sponsors & Collaborators

  • General Hospital, States of Jersey

    collaborator UNKNOWN

  • Clasado Limited

    lead INDUSTRY

Principal Investigators

  • Jelena Vulevic, phd · Clasado Research Services

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
52 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2018-03-31
Completion
2018-07-31

Countries

  • United Kingdom

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02716350 on ClinicalTrials.gov